1088
M. Alnabari, S. Bittner
PAPER
Table 1 Quinonic Enaminones 5−8
Products
5a
Yield1
(%)
Mp (∞C)
122-123
132-134
102-103
IR (KBr)
1H NMR (CDCl3)
d (ppm), J (Hz)
MS (m/z)
n cm−1
90
95
90
2960, 2890, 1583, 1497,
1439
8.25 (d, 1 H, J = 12.6), 5.64 (d, 1 H, J =
13.0), 3.48 (m, 4 H), 1.19 (t, 6 H)
310 [M+3H]+,
292, 280
5b
2955, 2911, 2851, 1664,
1581, 1525
8.54 (d, 1 H, J = 12.6), 7.45 (m, 5 H), 5.61
(d, 1 H, 12.8), 4.72 ( s, 2 H), 3.40 (s, 3 H)
357[ M+2H]+,
322, 265
5c2,3
2932, 2855, 1663, 1591,
1514
8.32 (d, 1 H, J = 12.8), 5.67 (d, 1 H, J =
12.5), 3.43−3.52 (m, 3 H), 1.15−1.85 (m,
13 H)
263 [M+2H]+,
326, 282
5d
5e
76
93
146-148
122-124
2961, 2820, 1659, 1588,
1521
8.32 (d, 1 H, J = 12.8), 5.58 (d, 1 H, J =
12.8), 3.23 (s, 6 H)
281 [M+2H]+,
248, 230, 168
2980, 2851, 1665, 1588,
1521
8.66 (d, 1 H, J = 13.0), 7.37 (s, 5 H), 7.24
(s, 5H), 5.88 (d, 1 H, J = 12.9), 4.50 (br s,
4 H)
434 [M+3H]+,
364, 305, 230,
196
6a
6b
76
65
130-132
148-149
2953, 2830, 1640, 1532,
1490
8.59 (d, 1 H, J = 13.0), 7.36 (br s, 10 H),
5.93 (d, 1 H, J = 12.8), 4.48 (br s, 4 H)
566 [M+3H]+,
487, 409, 344,
196
2965, 2889, 1600, 1497
8.49 (d, 1 H, J = 12.8), 7.40 (m, 5 H), 5.72
(d, 1 H, J = 12.9), 4.52 (s, 2 H), 2.91 (s, 3
H)
491 [M+3H]+,
487, 367, 334
6c
7a
7b
8a
67
50
44
90
140-142
148-150
132-134
96-97
2834, 2872, 1630, 1560
3165, 2198, 1563, 2970
3160, 2195, 2972, 1560
1674, 1599, 1569
8.26 (d, 1 H, J = 12.8), 5.78 (d, 1 H, J =
12.6), 3.49 (q, 4 H), 1.25 (t, 6 H)
425 [M+2H]+,
365, 342
8.89 (d, 1 H, J = 12.4), 7.34 (m, 10 H), 5.55
(d, 1 H), 4.62 (s, 2 H), 4.41 (s, 2 H)
417 [M+3H]+,
330, 180
8.53 (d, 1 H, J = 12.7), 5.54 (d, 1 H, J =
12.7), 3.76 (q, 4 H), 1.18 (t, 6 H)
291 [M+2H]+,
256, 204
8.70 (d, 1 H, J = 12.6), 8.15 (m,1 H), 7.99
(m, 1 H), 7.64 (m, 2 H), 7.34-7.39 (m, 5
H), 5.71 (d, 1 H, J = 12.9), 4.52 (s, 2 H),
2.88 (br s, 3 H)
340 [M+3H]+,
318, 304
8b
8c
8d
86
83
82
86-88
92-93
1678, 1670, 1562, 1591
1690, 1600,1570, 1495
1682, 1609, 1582, 1478
8.42 (d, 1 H, J = 12.9), 8.13 (m, 1 H), 7.95
(m, 1 H), 7.82 (m, 2 H), 5.61 (d, 1 H, J =
12.9), 3.46 (m, 4 H), 1.15 (t, 6 H)
292 [M+3H]+,
256, 218, 159
8.08 (m, 1 H), 7.95 (m, 1 H), 7.36 (d, 1 H,
J = 12.2), 7.08 (m, 2 H), 6.55 (m, 5 H), 5.63
(br s, 1 H), 3.01 (q, 2 H),1.16 (t, 3 H)
338 [M+H]+,
209, 192, 159
154-156
8.81 (d, 1 H, J = 13.0), 8.11 (m, 1 H), 7.99
(m, 1 H), 7.65 (m, 2 H), 7.39 (m, 5 H), 7.35
(m, 5 H), 5.92 (d, 1 H, J = 13.0), 4.49 (s, 4
H)
416 [M+3H]+,
378, 324, 288,
225
8e
90
118-119
2942, 1682, 1600, 1502,
1555
8.57 (d, 1 H, J = 12.7), 8.12 (m, 1 H), 7.98
(m, 1 H), 7.67 (m, 2 H), 5.76 (d, 1 H,
J = 13.0), 3.49 (m, 3 H), 1.89 (m, 4 H), 1.48
(m, 9 H)
344 [M+H]+,
310, 262, 226,
192, 159
1.Yields of isolated products based on the haloquinone were not optimized. Satisfactory microanalysis was obtained: C 0.31; H 0.19; N
0.28; Cl 36.
2
.
13C NMR (CDCl3): d (ppm) = 35, 61, 94, 128, 139, 140, 154, 177, 191. The other compounds also gave the correct 13CNMR spectra.
3. lmax (MeOH) = 208, 320, 694 nm. Similar absorptions were obtained for the other compounds.
Synthesis 2000, No. 8, 1087–1090 ISSN 0039-7881 © Thieme Stuttgart · New York